Regenerative Medical Technology (RMTG) Depreciation & Amortization - Total (2019 - 2026)

Regenerative Medical Technology has reported Depreciation & Amortization - Total for 8 years, with the latest figure at $66425.0 in Q2 2026.

• On a quarterly basis, Depreciation & Amortization - Total rose 118.17% year-over-year to $66425.0 in Q2 2026; TTM through Jun 2026 was $265385.0, a 278.46% increase from a year earlier, with the FY2025 full-year figure at $183527.0, up 49.18% from the prior year.
• Depreciation & Amortization - Total was $66425.0 for Q2 2026 at Regenerative Medical Technology, down from $73309.0 in the prior quarter.
• The five-year high for Depreciation & Amortization - Total was $98667.0 in Q3 2023, with the low at -$52196.0 in Q4 2024.
• Average Depreciation & Amortization - Total over 5 years is $42378.4, with a median of $51940.0 recorded in 2024.
• The largest YoY upside for Depreciation & Amortization - Total was 17462.5% in 2022 against a maximum downside of 273.66% in 2022.
• Over 5 years, Depreciation & Amortization - Total stood at -$46385.0 in 2022, then surged by 256.4% to $72547.0 in 2023, then sank by 171.95% to -$52196.0 in 2024, then jumped by 241.69% to $73958.0 in 2025, then dropped by 10.19% to $66425.0 in 2026.
• The last three Depreciation & Amortization - Total figures came in at $66425.0 (Q2 2026), $73309.0 (Q1 2026), and $73958.0 (Q4 2025), per Business Quant data.